Updates are available Correction dated 2020-11-03
Click to view Correction: https://doi.org/10.1007/s00392-020-01762-2
-
Authors
Santema, Bernadet T.
Chan, Michelle M. Y.
Tromp, Jasper
Dokter, Martin
van der Wal, Haye H.
Emmens, Johanna E.
Takens, Janny
Samani, Nilesh J.
Ng, Leong L.
Lang, Chim C.
van der Meer, Peter
ter Maaten, Jozine M.
Damman, Kevin
Dickstein, Kenneth
Cleland, John G.
Zannad, Faiez
Anker, Stefan D.
Metra, Marco
van der Harst, Pim
de Boer, Rudolf A.
van Veldhuisen, Dirk J.
Rienstra, Michiel
Lam, Carolyn S. P.
Voors, Adriaan A. http://orcid.org/0000-0002-5417-4415
-
Funding
Funding for this research was provided by:
FP7 Ideas: European Research Council (FP7-242209-BIOSTAT-CHF)
- License Information
-
More Information
Article History
Received: 12 March 2019
Accepted: 19 June 2019
First Online: 1 July 2019
Change Date: 3 November 2020
Change Type: Correction
Change Details: The original article can be found online.
Compliance with ethical standards
:
: SD.A. reports grants from Vifor and Abbott Vascular, and fees for consultancy from Vifor, Bayer, Boehringer Ingelheim, Brahms, Janssen, Novartis, Servier, Stealth Peptides, and ZS Pharma. K.Di. has received honoraria and/or research support from Medtronic, Boston Scientific St Jude, Biotronik and Sorin, and Merck, Novartis, Amgen, Pfizer, Sanofi, Abbott and Servier. C.C.L. received consultancy fees and/or research grants from Amgen, Astra Zeneca, MSD, Novartis, and Servier. D.vV. reports board membership fees/travel expenses from Johnson & Johnson, Novartis, Vifor, and Arca Biopharma. M.M. has received consulting honoraria from Amgen, Astra Zeneca, Novartis, Relypsa, and Servier, and speaker’s fees from Abbott Vascular and Servier. A.A.V. reports consultancy fees and/or research grants from: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, GSK, Myokardia, Novartis, Roche Diagnostics and Servier. All other authors declare no conflict of interest.
